KOSPI · 950210 · Biotech & Pharma · ₩950210

Prestige BioPharma프레스티지바이오파마

950210 · KOSPI · ₩950210 · 프레스티지바이오파마

₩4,220▼ ₩830 (16.44%)End-of-day · Oct 28, 2026 · End-of-day prices.

Trade

Sell Buy

Technical gauge

After the close on Oct 28, 2026

Short term

Bearish

1 bullish, 1 neutral, 7 bearish

Medium term

Bearish

0 bullish, 0 neutral, 8 bearish

What the indicators say

Prestige BioPharma closed at 5,050 won, below its 5-day (5,188), 20-day (5,656.5), 60-day (6,095.8), 120-day (6,392.8) and 200-day (8,133.6) moving averages, and inside a bearish trend on both short- and medium-term gauges (7 and 8 bearish signals, no bullish ones). Momentum is weak: RSI(14) is 26.4, stochastic %K is 5.5, MACD sits below its signal line with a negative histogram, ADX is 25.7 with minus DI (24.4) well above plus DI (9.5), and OBV is trending down, although volume is running at 2.4 times its 20-day average. Traders typically watch the support near 4,945 won, which sits just below the current price and near the lower Bollinger band at 4,977.4, and the resistance at 7,000 won, while the 20-day middle band stands at 5,656.5 won. Price is also trading below the Ichimoku cloud and about 89.3% above its 20-day average, with ATR at 6.1% of price.

Written by AI from the indicator values above. Not advice.

Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Squeeze! setup

1D timeframe

No squeeze setup on this stock right now.

Chart

Overlays

Panels

2026-10-28O 5,040H 5,110L 3,910C 4,220

Every indicator, chart overlays and the stock's recent technical events, with Pro.Unlock with Pro →

Indicators

Moving averagesPrice above 0 of 5 averages5d ₩4,958 · 20d ₩5,565 · 60d ₩6,074 · 120d ₩6,353 · 200d ₩8,090Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
RSI (14)Oversold (below 30)16.1Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
MACD (12, 26, 9)Below its signal line-331 · signal -224 · histogram -106The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
Bollinger Bands (20, 2)Near the lower band₩4,666 – ₩5,565 – ₩6,463 · width 32.3%Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
Volume vs 20-day averageHeavy trading21.61×Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.

Indicator	Value	Reading	What this typically means
Moving averages	5d ₩4,958 · 20d ₩5,565 · 60d ₩6,074 · 120d ₩6,353 · 200d ₩8,090	Price above 0 of 5 averages	Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
RSI (14)	16.1	Oversold (below 30)	Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
MACD (12, 26, 9)	-331 · signal -224 · histogram -106	Below its signal line	The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
Bollinger Bands (20, 2)	₩4,666 – ₩5,565 – ₩6,463 · width 32.3%	Near the lower band	Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
Volume vs 20-day average	21.61×	Heavy trading	Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.

Every indicator, chart overlays and the stock's recent technical events, with Pro.

Unlock with Pro

Technical events, last 90 days

Every indicator, chart overlays and the stock's recent technical events, with Pro.

Unlock with Pro

Short squeeze tracker. There isn't enough short-selling data for this stock yet. The tracker needs at least 20 trading days of short balances.

Share lending and returned shares

Shares lent out (mostly to short sellers), new loans and shares returned each day. A return is either the lender calling the shares back (a recall) or the borrower handing them back, often after buying back a short. The published figures don't say which.

Shares on loan: 595.7K; 1% of listed shares
Loans, 5-day change: 0.0%
Loans, 20-day change: +5.0%
Returned, last 5 days: 0
New loans, last 5 days: 0
Short balance vs loans: 0%; How much of the lent stock is sold short. The higher it is, the more buying back a wave of recalls forces.

Shares on loanReturned that dayUnusual return day

Unusual return days (last 60 days)

Day	Returned	Of the loans	Vs usual
Aug 31	63.5K	10.7%	635.2×

Unusual = at least 3× the 20-day average, at least 2% of the shares on loan and 10,000 shares.

As of Oct 28. Published figures, one trading day behind. They describe lending, not where the price goes; not a recommendation.

Lending data: Financial Services Commission, Korea (Public Data Portal).

Retail margin & forced selling

Forced-selling pulse10CalmOct 22, 2026

Margin loans

₩30T

−7.3% in 5 days · 8th percentile of the last year

Forced selling

₩11B

0.4× the 20-day average

Forced-sale share

1.0%

Unpaid settlements

₩1T

Retail stock borrowing ₩21B

Calm under 30, normal to 50, elevated to 70, high above. From today's forced-sale amount vs its 20-day average, the forced-sale share of receivables, where margin loans sit in their 1-year range, and whether they are being cut fast.

Estimates from public margin-lending statistics. Not a prediction or a recommendation.

Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Also known as: Prestige BioPharma / 프레스티지바이오파마 / 950210 / KRX:950210

Source: KRX statistical information